143 related articles for article (PubMed ID: 31395403)
21. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection.
Wald A; Ashley-Morrow R
Clin Infect Dis; 2002 Oct; 35(Suppl 2):S173-82. PubMed ID: 12353203
[TBL] [Abstract][Full Text] [Related]
22. Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.
Ohana B; Lipson M; Vered N; Srugo I; Ahdut M; Morag A
Clin Diagn Lab Immunol; 2000 Nov; 7(6):904-8. PubMed ID: 11063496
[TBL] [Abstract][Full Text] [Related]
23. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
Morrow RA; Friedrich D; Meier A; Corey L
BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
[TBL] [Abstract][Full Text] [Related]
24. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics.
Whittington WL; Celum CL; Cent A; Ashley RL
Sex Transm Dis; 2001 Feb; 28(2):99-104. PubMed ID: 11234793
[TBL] [Abstract][Full Text] [Related]
25. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
[TBL] [Abstract][Full Text] [Related]
26. Performance and use of HSV type-specific serology test kits.
Ashley RL
Herpes; 2002 Jul; 9(2):38-45. PubMed ID: 12106510
[TBL] [Abstract][Full Text] [Related]
27. Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: A comparative study in Indian population from a tertiary care hospital.
Patwardhan V; Bhalla P
Indian J Pathol Microbiol; 2016; 59(3):318-21. PubMed ID: 27510668
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay.
Enders G; Risse B; Zauke M; Bolley I; Knotek F
Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):870-2. PubMed ID: 10052553
[TBL] [Abstract][Full Text] [Related]
29. Peptide based enzyme-linked immunoassays for detection of anti-HSV-2 IgG in human sera.
Oladepo DK; Klapper PE; Marsden HS
J Virol Methods; 2000 Jun; 87(1-2):63-70. PubMed ID: 10856753
[TBL] [Abstract][Full Text] [Related]
30. Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing.
Crawford KHD; Selke S; Pepper G; Goecker E; Sobel A; Wald A; Johnston C; Greninger AL
J Clin Microbiol; 2024 Jun; 62(6):e0026324. PubMed ID: 38687020
[TBL] [Abstract][Full Text] [Related]
31. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
Al-Sulaiman AM; Vallely PJ; Klapper PE
Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
Eing BR; Lippelt L; Lorentzen EU; Hafezi W; Schlumberger W; Steinhagen K; Kühn JE
J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera.
Eis-Hübinger AM; Däumer M; Matz B; Schneweis KE
J Clin Microbiol; 1999 May; 37(5):1242-6. PubMed ID: 10203464
[TBL] [Abstract][Full Text] [Related]
34. Recombinant glycoprotein G analog for determination of specific immunoglobulins to herpes simplex virus type 2 by ELISA.
Korshun L; Vudmaska M; Moysa L; Kovtonjuk G; Mikhalap S; Ganova L; Spivak N
J Virol Methods; 2013 Dec; 194(1-2):67-73. PubMed ID: 23933396
[TBL] [Abstract][Full Text] [Related]
35. Whole cell lysate enzyme immunoassays vs. recombinant glycoprotein G2-based immunoassays for HSV-2 seroprevalence studies.
García-Corbeira P; Hogrefe W; Aguilar L; García-de-Lomas J; Gil A; Bayas JM; Vilella A; Dal-Ré R
J Med Virol; 1999 Dec; 59(4):502-6. PubMed ID: 10534733
[TBL] [Abstract][Full Text] [Related]
36. Mapping of linear antigenic determinants on glycoprotein C of herpes simplex virus type 1 and type 2 recognized by human serum immunoglobulin G antibodies.
Ackermann G; Ackermann F; Eggers HJ; Wieland U; Kühn JE
J Med Virol; 1998 Aug; 55(4):281-7. PubMed ID: 9661836
[TBL] [Abstract][Full Text] [Related]
37. Is HSV serology useful for the management of first episode genital herpes?
Page J; Taylor J; Tideman RL; Seifert C; Marks C; Cunningham A; Mindel A
Sex Transm Infect; 2003 Aug; 79(4):276-9. PubMed ID: 12902573
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
39. Comparison of immunoassays for differentiation of herpes simplex virus type 1 and 2 antibodies.
Qutub MO; Klapper PE; Vallely PJ; Cleator GM; Mandall D
Saudi Med J; 2006 Jun; 27(6):788-93. PubMed ID: 16758036
[TBL] [Abstract][Full Text] [Related]
40. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype-specific diagnosis.
Marsden HS; MacAulay K; Murray J; Smith IW
J Med Virol; 1998 Sep; 56(1):79-84. PubMed ID: 9700637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
